Newsletter - May 19, 2016
Opioid Regulations on Steroids: No Pun Intended
In an unprecedented bipartisan move, last week the US Congress passed 18 bills to curb opioid abuse, most of which will have a direct impact on how physicians prescribe these drugs. Along with the CDC recommendations for training and prescribing rules for doctors and the Comprehensive Opioid Abuse Reduction Act (CARA) passed earlier in March, these new laws highlight the various aspects of the opioid abuse epidemic where better training and medical practice are needed. Read More..
Clinical Trial Results and Clinical Trial Protocol Mismatch
Clinical trial transparency has been a concern for a long time. An analysis by researchers at the University of Oxford found that more than 40% of the trial results published in the top 5 medical journals corresponded to new endpoints not included in the clinical protocol. In some case, none of the outcomes listed in the clinical protocol were discussed in the article published upon completion of the trial. Read More..
Opioid Regulations on Steroids: No Pun Intended
In an unprecedented bipartisan move, last week the US Congress passed 18 bills to curb opioid abuse, most of which will have a direct impact on how physicians prescribe these drugs. Along with the CDC recommendations for training and prescribing rules for doctors and the Comprehensive Opioid Abuse Reduction Act (CARA) passed earlier in March, these new laws highlight the various aspects of the opioid abuse epidemic where better training and medical practice are needed. Read More..
Clinical Trial Results and Clinical Trial Protocol Mismatch
Clinical trial transparency has been a concern for a long time. An analysis by researchers at the University of Oxford found that more than 40% of the trial results published in the top 5 medical journals corresponded to new endpoints not included in the clinical protocol. In some case, none of the outcomes listed in the clinical protocol were discussed in the article published upon completion of the trial. Read More..